苯甲酰芍藥苷
分析標(biāo)準(zhǔn)品,HPLC≥98%
Benzoylpaeoniflorin
CAS號(hào)：38642-49-8
分子式：C30H32O12
分子量：584.57
MDL：MFCD00869479
貨號(hào) | 規(guī)格/參數(shù)/品牌 | 價(jià)格 | 貨期 |
YJ-B20086-20mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥700.00 | 現(xiàn)貨 |
YJ-B20086-100mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥2100.00 | 現(xiàn)貨 |
產(chǎn)品介紹
沸點(diǎn)：733.8℃ at 760 mmHg
外觀：白色結(jié)晶粉末
溶解性：DMSO:≥34mg/mL(58.16mM)
儲(chǔ)存條件：2-8℃
注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。
參考文獻(xiàn)(30篇)
30. [IF=6.2] Jing Wang et al."Processing of vinegar-processed Paeoniae Radix Alba: A study on processing optimization, sensory quality, processing excipients, pilot-scale production, and quality control."Applied Food Research.2025 Jun;:101066
29. [IF=3.1] Yan Cao et al."Tissue-specific chemical expression and quantitative analysis of bioactive components of Moutan Cortex by laser-microdissection combined with UPLC-Q-Orbitrap-MS technique."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.2024 Oct;:116537
28. [IF=5.6] Jing Yang et al."Isolation, purification and comparison of soluble active substances from four peony roots."INDUSTRIAL CROPS AND PRODUCTS.2024 Dec;222:119886
27. [IF=5.6] Siyi Ma et al."Integration of feature-based molecular networking and high-definition data-dependent acquisition for the comprehensive multicomponent characterization of Honghua Xiaoyao Tablet."TALANTA.2025 Apr;285:127298
26. [IF=5.6] Yixuan Wang et al."Anti-melanogenesis activity and chemical profiling of herbaceous peony (Paeonia lactiflora Pall.) flowers: A natural skin whitening agents containing Paeonia monoterpene glycosides."INDUSTRIAL CROPS AND PRODUCTS.2025 Mar;225:120363
25. [IF=2.6] Zengfa Wang et al."Baicalein antagonises Rhopilema esculentum toxin-induced oxidative stress and apoptosis by modulating ROS-MAPK-NF-κB and inhibiting PLA2 activity."TOXICON.2025 Jan;:108266
24. [IF=7.9] Yuan Chen et al."Exploring the anti-skin inflammation substances and mechanism of Paeonia lactiflora Pall. Flower via network pharmacology-HPLC integration."PHYTOMEDICINE".2024 Jul;129:155565
23. [IF=5.4] Hui Ren et al."Integrated serum metabolomics and network pharmacology analysis on the bioactive metabolites and mechanism exploration of Bufei huoxue capsule on chronic obstructive pulmonary disease rats."JOURNAL OF ETHNOPHARMACOLOGY.2024 Apr;324:117816
22. [IF=5.4] Yingqiu Shi et al."Effective constituents and protective effect of Mudan granules against Schwann cell injury."JOURNAL OF ETHNOPHARMACOLOGY.2024 Apr;323:117692
21. [IF=3.4] Jiaxin Yin et al."Comprehensive multicomponent characterization and quality assessment of Xiaoyao Wan by UPLC-Q-Orbitrap-MS, HS-SPME-GC-MS and HS-GC-IMS."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.2024 Feb;239:115910
20. [IF=5.4] Yanhui Zhao et al."Danggui Shaoyao San: Chemical characterization and inhibition of oxidative stress and inflammation to treat CCl4-induced hepatic fibrosis."JOURNAL OF ETHNOPHARMACOLOGY.2023 Jul;:116870
19. [IF=4.36] Li-Mei Feng et al."An integrated strategy for discovering effective components of Shaoyao Gancao decoction for treating neuropathic pain by the combination of partial least-squares regression and multi-index comprehensive method."J Ethnopharmacol. 2020 Oc
18. [IF=4.36] Qiyang Shou et al."Total glucosides of peony improve ovalbumin-induced allergic asthma by inhibiting mast cell degranulation."J Ethnopharmacol. 2019 Nov;244:112136
17. [IF=4.759] Xu Wang et al."A rapid and practical prediction method for the Arizona solvent system family used in high speed countercurrent chromatography."J Chromatogr A. 2020 Oct;1629:461426
16. [IF=6.576] Luo Zhiqiang et al."Mechanism of Paeoniae Radix Alba in the Treatment of Non-alcoholic Fatty Liver Disease Based on Sequential Metabolites Identification Approach, Network Pharmacology, and Binding Affinity Measurement."Front Nutr. 2021 Sep;0:674
15. [IF=1.963] Yujie Lu et al."Searching for calcium antagonists for hypertension disease therapy from Moutan Cortex, using bioactivity integrated UHPLC‐QTOF‐MS."Phytochem Analysis. 2019 Jul;30(4):456-463
14. Li-Mei Feng, Yan-Yan Chen, Ding-Qiao Xu, Rui-Jia Fu, Shi-Jun Yue, Qi Zhao, Yu-Xi Huang, Xue Bai, Mei Wang, Li-Ming Xing, Yu-Ping Tang, Jin-Ao Duan,
An integrated strategy for discovering effective components of Shaoyao Gancao decoction for treating neuropa
13. Li-Mei Feng, Yan-Yan Chen, Ding-Qiao Xu, Rui-Jia Fu, Shi-Jun Yue, Qi Zhao, Yu-Xi Huang, Xue Bai, Mei Wang, Li-Ming Xing, Yu-Ping Tang, Jin-Ao Duan,
An integrated strategy for discovering effective components of Shaoyao Gancao decoction for treating neuropa
12. 程江雪, 唐志書, 郭東艷, et al. 不同配伍配比對(duì)赤芍-當(dāng)歸藥對(duì)中10個(gè)成分溶出量的影響研究[J]. 藥物分析雜志, 2019, v.39(09):73-80.
11. 趙園園,梁德勤,金傳山,魏慶紅,張偉,許鳳清,王林.基于HPLC指紋圖譜的亳白芍不同炮制品標(biāo)準(zhǔn)湯劑7個(gè)成分含量測(cè)定[J].天然產(chǎn)物研究與開發(fā),2018,30(03):404-411+500.
10. 付士朋, 沈宏偉, 王謙博,等. 赤芍飲片加工工藝的優(yōu)化[J]. 中成藥, 2019(8).
9. 付士朋, 沈宏偉, 王謙博,等. 指紋圖譜結(jié)合灰色關(guān)聯(lián)度分析法對(duì)不同產(chǎn)地赤芍質(zhì)量的評(píng)價(jià)研究[J]. 中草藥 2019年50卷23期, 5865-5871頁, ISTIC PKU CSCD CA, 2019.
8. 梁德勤, 趙園園, 羅云,等. 不同加工方式亳白芍的高效液相指紋圖譜及多成分含量比較[J]. 安徽中醫(yī)藥大學(xué)學(xué)報(bào), 2018.
7. 王化, 何丹嬈, 朱良玉,等. HPLC法同時(shí)測(cè)定赤芍中9個(gè)活性成分的含量[J]. 中草藥, 2018, 049(003):708-711.
6. 莫雨佳, 王彥, 齊琪,等. 經(jīng)典名方散偏湯HPLC指紋圖譜的建立及川芎的量值傳遞研究[J]. 中國(guó)中藥雜志, 2020, v.45(03):122-128.
5. 佘守軍, 鄭如程, 羅琴,等. 正交試驗(yàn)優(yōu)化鳳丹皮中單萜苷的煎煮工藝[J]. 湖北醫(yī)藥學(xué)院學(xué)報(bào), 2019, 38(02):140-142.
4. 佘守軍 鄭如程 代算算 等. 不同方法提取亳州牡丹皮中3種單萜苷的比較研究[J]. 宜春學(xué)院學(xué)報(bào) 2019(9):32-36.
3. 于現(xiàn)花 高海燕 金傳山 等. 不同產(chǎn)地白芍標(biāo)準(zhǔn)煎液的指紋圖譜及4種單萜苷類成分含量測(cè)定[J]. 中國(guó)現(xiàn)代應(yīng)用藥學(xué) 2020(11):1290-1295.
2. 佘守軍 鄭如程 陳蕾 等. Box-Behnken響應(yīng)面法優(yōu)選鳳丹皮中苷類成分的醇提工藝[J]. 陜西中醫(yī)藥大學(xué)學(xué)報(bào) 2019 042(004):21-27.
1. 許源, 劉培, 嚴(yán)輝,等. 白芍初加工過程中單萜苷類及多羥基化合物的變化分析[J]. 中藥材, 2014(5):775-780.
從2011年開始我們致力于在生命科學(xué)領(lǐng)域、生物醫(yī)學(xué)實(shí)驗(yàn)技術(shù)及論文潤(rùn)色服務(wù)，協(xié)助客戶各類實(shí)驗(yàn)服務(wù)及論文潤(rùn)色十多年，是您值得信賴的科研合作伙伴!
如果您受時(shí)間、試驗(yàn)條件等限制而無法完成您的課題研究，歡迎您與我們聯(lián)系。
實(shí)驗(yàn)技術(shù)服務(wù)：
實(shí)驗(yàn)室代做實(shí)驗(yàn)項(xiàng)目
| |||
細(xì)胞熒光染料標(biāo)記檢測(cè)實(shí)驗(yàn)
| |||
| |||
染色質(zhì)免疫沉淀分析(CLIP)實(shí)驗(yàn)服務(wù)
| |||
| |||
|
